Pilot and Feasibility Program
Pilot and Feasibility Program
批准号:
10585209
负责人:
Scott Soleimanpour
金额:
$39.71万
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
未结题
起止时间:
1996-12-01 至 2027-11-30
关键词:
AccelerationApplications GrantsAreaAwardBiomedical ResearchClinicalClinical ResearchCollaborationsCommunicationCost SharingDataDiabetes MellitusDisciplineEligibility DeterminationEndocrine System DiseasesEquilibriumExpenditureExtramural ActivitiesFacultyFosteringFundingGoalsGrantGrant ReviewInstitutionInstructionInterdisciplinary StudyManuscriptsMetabolic DiseasesMichiganMonitorPaperPeer ReviewProcessProgress ReportsPublicationsPublishingRecording of previous eventsReportingResearchResearch PersonnelResearch SupportResourcesReview CommitteeSchoolsScienceTimeUnited States National Institutes of HealthUniversitiesWorkcareerfollow-upinnovationinterdisciplinary collaborationinterestmemberpreventprogramsrecruitresearch faculty
中文摘要
项目摘要/摘要-MDRC试点和可行性赠款计划
密歇根糖尿病研究中心(MDRC)试点项目的目的和可行性(P/F)补助金计划
是鼓励在糖尿病及其并发症以及相关内分泌和代谢领域进行新的研究
精神错乱。这项研究可能是基础生物医学领域,也可能是临床研究领域。本节目
每年至少提供250,000美元的P/F奖助金;可能会为
使用密歇根大学(U-M)提供的资金的高评级申请。MDRC P/F计划
将资助两种类型的奖励:(1)具有单一PI的标准一年50,000美元P/F奖励,(2)两年期,
100,000美元的糖尿病跨学科研究计划(DISP)奖项,旨在支持和促进新的
来自不同学科的两名或更多密歇根大学教职员工之间的合作,以专注于他们的组合
糖尿病研究前沿领域的研究优势。每年,MDRC都会征集申请
来自密歇根大学全职教学或研究人员的P/F和DISP助学金。符合条件的包括:1)新增
没有过去或目前NIH研究支持的研究人员开始了糖尿病研究的职业生涯,
2)以前没有从事过糖尿病研究但希望将重点放在
糖尿病方面的专业知识,以及3)成熟的糖尿病研究人员,他们在
这与他们正在进行的研究明显背道而驰。最优先考虑的是新的
调查人员。申请从密歇根大学积极征求,并由两个或更多人进行同行审查
在申请领域具有专业知识的校外审查员。批准具有最高价值的申请,
根据这一审查过程和MDRC赠款计划咨询委员会的判断,将获得奖项。这个
标准P/F和DISP奖之间的余额每年可能会有所不同,具体取决于
每种奖项类型的申请强度。该计划的最终目标是使获奖者能够
产生足够的初步数据,以支持成功地从
美国国立卫生研究院或其他国家授权机构。MDRC P/F赠款计划吸引了来自不同领域的研究人员
密歇根大学的学校、部门和研究所致力于糖尿病相关研究,并培养新的、创新的、
在密歇根大学进行跨学科和协作的糖尿病研究。
英文摘要
Project Summary/Abstract - MDRC Pilot and Feasibility Grants Program
The purpose of the Michigan Diabetes Research Center (MDRC) Pilot and Feasibility (P/F) Grants Program
is to stimulate new research in the areas of diabetes, its complications, and related endocrine and metabolic
disorders. This research may be in areas of basic biomedical science or clinical research. This program
provides a minimum of $250,000 per year for P/F grant awards; additional funding may be provided for
highly-rated applications using funds provided by the University of Michigan (U-M). The MDRC P/F program
will fund two types of awards: (1) standard one-year $50,000 P/F awards with a single PI, and (2) two-year,
$100,000 Diabetes Interdisciplinary Studies Program (DISP) awards that seek to support and promote new
collaborations between two or more U-M faculty members from distinct disciplines, to focus their combined
research strengths on cutting-edge areas in diabetes research. Each year, the MDRC solicits applications for
P/F and DISP grants from full-time instructional or research faculty at U-M. Those eligible include: 1) new
investigators without past or current NIH research support who are beginning careers in diabetes research,
2) established investigators who have not previously worked in diabetes research but wish to focus their
expertise on diabetes, and 3) established diabetes investigators who propose innovative research in
diabetes that represents a clear departure from their ongoing research. Highest priority is given to new
investigators. Applications are actively solicited from across U-M and are peer-reviewed by two or more
extramural reviewers with expertise in the area of the application. Grant applications with the highest merit,
as judged by this review process and the MDRC Grants Program Advisory Council, receive awards. The
balance between standard P/F and DISP awards may vary from year to year, depending upon the relative
strength of applications for each award type. The ultimate goal of the program is to enable awardees to
generate sufficient preliminary data to support a successful application for major research funding from the
NIH or another national granting agency. The MDRC P/F Grants Program attracts investigators from diverse
U-M schools, departments, and institutes into diabetes-related research and fosters new, innovative,
interdisciplinary, and collaborative diabetes research at U-M.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Type 2 diabetes risk variant effects on mitochondrial (patho)physiology
-
批准号:10717519
-
项目类别:
-
资助金额:$78.88万
-
财政年份:2023
-
负责人:Scott Soleimanpour
-
依托单位:
Control of beta cell identity by the mitochondrial life cycle
-
批准号:10619610
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Scott Soleimanpour
-
依托单位:
Control of beta cell identity by the mitochondrial life cycle
-
批准号:9890737
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Scott Soleimanpour
-
依托单位:
Control of beta cell identity by the mitochondrial life cycle
-
批准号:10454761
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Scott Soleimanpour
-
依托单位:
Mediators of mitophagy in the regulation of beta cell function
-
批准号:9237051
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2016
-
负责人:Scott Soleimanpour
-
依托单位:
Mediators of mitophagy in the regulation of beta cell function
-
批准号:9761533
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2016
-
负责人:Scott Soleimanpour
-
依托单位:
Endosomal regulation of GLP-1 receptor function in beta cells by Clec16a
-
批准号:9086362
-
项目类别:
-
资助金额:$7.75万
-
财政年份:2015
-
负责人:Scott Soleimanpour
-
依托单位:
Endosomal regulation of GLP-1 receptor function in beta cells by Clec16a
-
批准号:8949507
-
项目类别:
-
资助金额:$7.75万
-
财政年份:2015
-
负责人:Scott Soleimanpour
-
依托单位:
The Role of Clec16a in the Pancreatic Islet
-
批准号:8394578
-
项目类别:
-
资助金额:$15.51万
-
财政年份:2012
-
负责人:Scott Soleimanpour
-
依托单位:
The Role of Clec16a in the Pancreatic Islet
-
批准号:8242336
-
项目类别:
-
资助金额:$15.51万
-
财政年份:2012
-
负责人:Scott Soleimanpour
-
依托单位:
The Role of Clec16a in the Pancreatic Islet
-
批准号:8594240
-
项目类别:
-
资助金额:$15.51万
-
财政年份:2012
-
负责人:Scott Soleimanpour
-
依托单位:
The Role of Clec16a in the Pancreatic Islet
-
批准号:8984302
-
项目类别:
-
资助金额:$15.51万
-
财政年份:2012
-
负责人:Scott Soleimanpour
-
依托单位:
Expanded (Regional) Pilot and Feasibility Program
-
批准号:10585210
-
项目类别:
-
资助金额:$23.27万
-
财政年份:1996
-
负责人:Scott Soleimanpour
-
依托单位: